Tenaya Therapeutics (TNYA) director receives 120,000 stock options at $0.7989
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Tenaya Therapeutics, Inc. director Catherine Stehman-Breen received a grant of stock options covering 120,000 shares of common stock. These options have an exercise price of $0.7989 per share and were granted as compensation, not through an open-market purchase.
The option grant was made under the Amended and Restated Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan and will vest in full on May 28, 2027, or earlier on the day immediately before the next annual meeting of stockholders after the grant date, if that comes first, provided she continues as a service provider. The options expire on May 27, 2036, and following this grant she holds 120,000 options of this award.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Stehman-Breen Catherine
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to buy) | 120,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to buy) — 120,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 120,000 options
Exercise price: $0.7989 per share
Underlying shares: 120,000 shares
+3 more
6 metrics
Option grant size
120,000 options
Stock Option (Right to buy) granted to director
Exercise price
$0.7989 per share
Conversion or exercise price of option grant
Underlying shares
120,000 shares
Common Stock underlying the options
Post-transaction holdings (this award)
120,000 options
Total options following transaction for this grant
Vesting date
May 28, 2027
Full vesting date or earlier before next annual meeting
Expiration date
May 27, 2036
Option term end date
Key Terms
Stock Option (Right to buy), exercise price, Equity Incentive Plan, vesting, +1 more
5 terms
Stock Option (Right to buy) financial
"security_title: "Stock Option (Right to buy)""
exercise price financial
"conversion_or_exercise_price: "0.7989""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Equity Incentive Plan financial
"Option granted pursuant to the Amended and Restated Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan."
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
vesting financial
"Option will vest in full May 28, 2027, or, if earlier, the day immediately before the date of the next annual meeting"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: "2036-05-27T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What did Catherine Stehman-Breen acquire in this Tenaya Therapeutics (TNYA) Form 4?
Catherine Stehman-Breen received a grant of stock options for 120,000 shares of Tenaya Therapeutics common stock. The options were awarded as compensation, not bought in the market, and give her the right to purchase shares at a fixed exercise price.
What is the exercise price of the stock options granted to the Tenaya Therapeutics (TNYA) director?
The stock options have an exercise price of $0.7989 per share. This means Stehman-Breen can purchase Tenaya Therapeutics common stock at $0.7989 per share once the options vest and before they expire, subject to the plan’s terms and her continued service.
When do Catherine Stehman-Breen’s Tenaya Therapeutics (TNYA) options vest and expire?
The options will vest in full on May 28, 2027, or earlier on the day immediately before the next annual meeting of stockholders after the grant date. They have an expiration date of May 27, 2036, defining the period during which they can be exercised.
How many Tenaya Therapeutics (TNYA) options does Catherine Stehman-Breen hold after this Form 4 transaction?
Following the reported grant, Stehman-Breen holds 120,000 stock options from this award. These options relate to 120,000 shares of Tenaya Therapeutics common stock and are subject to the vesting schedule and other conditions outlined in the company’s 2021 Equity Incentive Plan.
Is the Tenaya Therapeutics (TNYA) Form 4 transaction an open-market buy or a compensation grant?
The Form 4 shows a compensation-related grant, not an open-market purchase. The transaction is coded as an award of stock options under the Amended and Restated 2021 Equity Incentive Plan, with no cash purchase of shares reported in the transaction details.